Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD

Perspectives

Avoiding Pressure Injuries in Long-Term Care

11/17/2023

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

This article helps long-term care professionals distinguish between avoidable and unavoidable pressure injuries and highlights the need for individualized care plans. Upon admission, thorough skin assessments and identification of risk...

This article helps long-term...

11/17/2023

Annals of Long-Term Care

Clinical Pathways GPS

Clinical Pathways: Expanding Beyond Pharmaceuticals

04/20/2022

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Dr Stefanacci explains how changes in our clinical pathways will greatly expand our treatment options, providing significant improvement in both clinical and financial outcomes.

Dr Stefanacci explains how...

04/20/2022

Journal of Clinical Pathways

Clinical Pathways GPS

Are Clinical Pathways Addressing Glasses Half Full, Half Empty or Simply Too Big?

11/16/2021

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard Stefanacci, DO, gives feedback on the current state of clinical pathways and identifies areas for improvement, including patient engagement and education, best practice incentives, and electronic health record integration.

Richard Stefanacci, DO, gives...

11/16/2021

Journal of Clinical Pathways

Clinical Pathways GPS

Patients’ Care Journey via the Internet

09/24/2021

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the shift from patients being a passive party in their health to becoming an active force in every aspect of care, from diagnosis to treatment to adherence.

Richard G Stefanacci, DO, MGH,...

09/24/2021

Journal of Clinical Pathways

Feature

Malnutrition Management: A Clinical Pathway Model for Symptom Management

06/14/2017

Emily Chan , MD;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Nader Tavakoli , MD, CMD, FAAFP;

Christopher Riley , MD;

Paul Newman , MD, MBA, MS;

Abstract: Although clinical pathways are most often developed for very narrow diagnoses with limited pharmaceutical treatments, they are even more needed to provide direction for symptom management involving multiple...

...

06/14/2017

Journal of Clinical Pathways